• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

Behavioural disturbances in AD: topiramate vs. risperidone

April 28, 2010  

SSRIs in Alzheimer’s disease: mixed results

March 30, 2010  

Ginkgo ineffective at preventing cognitive decline

March 30, 2010  

Behavioural symptoms appear improved with prazosin

March 2, 2010  

CSF biomarkers of AD in MCI patients

February 2, 2010  

No cognitive benefit with folate, vitamin B supplementation

February 2, 2010  

Thyroid medication use linked to AD risk

December 1, 2009  

CIHR, Quebec and France collaborate on Alzheimer disease research

October 6, 2009  

Comparing treatments for behavioural and psychological symptoms

August 11, 2009  

Diabetes a risk factor for MCI, Alzheimer’s disease

August 11, 2009  
Previous
5
6
7
8
9
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions